#vitiligo — top 20, last 30d
| 0 | ℹ |
Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials.
(nature.com)
|
Nature Medicine 2026-11-02 | #vitiligo #clinical trial #immunology #dermatology #jak inhibitor |